Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

SUPN holding history

Supernus Pharmaceuticals, Inc. in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings

Shares (Q2 2026)
140,207
Value
$6.52M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of SUPN by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026140,207$6.52M<0.1%+93,580+200.7%AddedHolders
Q1 202646,627$2.41M<0.1%+16,823+56.4%AddedHolders
Q4 202529,804$1.48M<0.1%−41,054−57.9%ReducedHolders
Q3 202570,858$3.39M<0.1%−18,231−20.5%ReducedHolders
Q2 202589,089$2.81M<0.1%+16,791+23.2%AddedHolders
Q1 202572,298$2.37M<0.1%+45,279+167.6%AddedHolders
Q4 202427,019$977.0K<0.1%−25,048−48.1%ReducedHolders
Q3 202452,067$1.62M<0.1%+30,574+142.3%AddedHolders
Q2 202421,493$574.9K<0.1%−29,297−57.7%ReducedHolders
Q1 202450,790$1.73M<0.1%−4,282−7.8%ReducedHolders
Q4 202355,072$1.59M<0.1%+3,829+7.5%AddedHolders
Q3 202351,243$1.41M<0.1%+16,372+47.0%AddedHolders
Q2 202334,871$1.05M<0.1%+19,330+124.4%AddedHolders
Q1 202315,541$563.0K<0.1%+771+5.2%AddedHolders
Q4 202214,770$526.8K<0.1%−45,821−75.6%ReducedHolders
Q3 202260,591$2.05M<0.1%−5,621−8.5%ReducedHolders
Q2 202266,212$1.92M<0.1%+66,212NewHolders
Q4 20210$00.0%−110,227−100.0%Sold outHolders
Q3 2021110,227$2.94M<0.1%−91,261−45.3%ReducedHolders
Q2 2021201,488$6.20M<0.1%+118,394+142.5%AddedHolders
Q1 202183,094$2.17M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.